Plasma urocortin levels in the diagnosis of ovarian endometriosis

Obstetrics and Gynecology

Volumn 110, Issue 3, 2007, Pages 594-600

  Florio, Pasquale ^a   Reis, Fernando M ^b   Torres, Paulo B ^b   Calonaci, Francesco ^b   Toti, Paolo ^b   Bocchi, Caterina ^b   Linton, Elizabeth A ^b   Petraglia, Felice ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; UROCORTIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CAPILLARY BLOOD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYST FLUID; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MEASUREMENT; OVARY CYST; PARITY; PELVIS PAIN SYNDROME; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE; CAPILLARY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; STROMA CELL;

ADULT; ASCITIC FLUID; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CORTICOTROPIN-RELEASING HORMONE; CYST FLUID; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN CYSTS; OVARIAN DISEASES; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 34548409502     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000278572.86019.ae     Document Type: Article

References (32)

1. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-99.
2. Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril 2006;85:564-72.
3. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995;378:287-92.
4. Guerriero S, Mais V, Ajossa S, Paoletti AM, Angiolucci M, Melis GB. Transvaginal ultrasonography combined with CA-125 plasma levels in the diagnosis of endometrioma. Fertil Steril 1996;65:293-8.
5. Florio P, Arcuri F, Ciarmela P, Runci Y, Romagnoli R, Cintorino M, et al. Identification of urocortin mRNA and peptide in the human endometrium. J Endocrinol 2002;173:R9-14.
6. Florio P, Vale W, Petraglia F. Urocortins in human reproduction. Peptides 2004;25:1751-7.
7. Torricelli M, De Falco G, Florio P, Rossi M, Leucci E, Vigano P, et al. Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum Reprod 2007;22:92-6.
8. Li W, Challis JR. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. J Clin Endocrinol Metab 2005;90:6569-74.
9. Baigent SM. Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 2001;22:809-20.
10. Bale TL, Giordano FJ, Vale WW. A new role for corticotropin-releasing factor receptor-2: suppression of vascularization. Trends Cardiovasc Med 2003;13:68-71.
11. Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, et al. Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab 1999;84:2802-6.
12. American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985;43:351-2.
13. Florio P, Torricelli M, Galleri L, De Falco G, Leucci E, Calonaci G, et al. High fetal urocortin levels at term and preterm labor. J Clin Endocrinol Metab 2005;90:5361-5.
14. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983;148:839-43.
15. Stephan C, Wesseling S, Schink T, Jung K. Comparison of eight computer programs for receiver-operating characteristic analysis. Clin Chem 2003;49:433-9.
16. Flahault A, Cadilhac M, Thomas G. Sample size calculation should be performed for design accuracy in diagnostic test studies. J Clin Epidemiol 2005;859-62.
17. Khan KS, Khan SF, Nwosu CR, Arnott N, Chien PF. Misleading authors' inferences in obstetric diagnostic test literature. Am J Obstet Gynecol 1999;181:112-5.
18. Graziani G, Tentori L, Portarena I, Barbarino M, Tringali G, Pozzoli G, et al. CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway. Endocrinology 2002;143:807-13.
19. Florio P, De Falco G, Leucci E, Torricelli M, Torres PB, Toti P, et al. Urocortin expression is downregulated in human endometrial carcinoma. J Endocrinol 2006;190:99-105.
20. Collette T, Maheux R, Mailloux J, Akoum A. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. Hum Reprod 2006;21:3059-67.
21. Ness RB, Modugno F. Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers. Eur J Cancer 2006;42:691-703.
22. Kempuraj D, Papadopoulou N, Stanford EJ, Christodoulou S, Madhappan B, Sant GR, et al. Increased numbers of activated mast cells in endometriosis lesions positive for corticotropinreleasing hormone and urocortin. Am J Reprod Immunol 2004;52:267-75.
23. Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, et al. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci U S A 2002;99:7734-39.
24. Guerriero S, Ajossa S, Mais V, Risalvato A, Lai MP, Melis GB. The diagnosis of endometriomas using colour Doppler energy imaging. Hum Reprod 1998;13:1691-95.
25. Groothuis PG, Nap AW, Winterhager E, Grummer R. Vascular development in endometriosis. Angiogenesis 2005;8: 147-56.
26. Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998;70:1101-8.
27. Eskenazi B, Warner M, Bonsignore L, Olive D, Samuels S, Vercellini P. Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril 2001;76:929-35.
28. Charles CJ, Rademaker MT, Richards AM, Yandle TG. Plasma urocortin 1 in sheep: regional sampling and effects of experimental heart failure. Peptides 2006;27:1801-5.
29. Ng LL, Loke IW, O'Brien RJ, Squire IB, Davies JE. Plasma urocortin in human systolic heart failure. Clin Sci (Lond) 2004;106:383-8.
30. Florio P, Torricelli M, De Falco G, Leucci E, Giovannelli A, Gazzolo D, et al. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension. J Hypertens 2006;24:1831-40.
31. Torricelli M, Ignacchiti E, Giovannelli A, Merola A, Scarpetti E, Calonaci G, et al. Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies. Eur J Endocrinol 2006;154:281-5.
32. Fukuda T, Takahashi K, Suzuki T, Saruta M, Watanabe M, Nakata T, et al. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders. J Clin Endocrinol Metab 2005;90:4671-8.